{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:55Z","timestamp":1789799935910,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13299-y","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:38:40Z","timestamp":1734536320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The performance of JAM3\/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection"],"prefix":"10.1186","volume":"24","author":[{"given":"Dan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfa","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"13299_CR1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fonc.2020.00914","volume":"10","author":"S Allouch","year":"2020","unstructured":"Allouch S, Malki A, Allouch A, et al. High-risk hpv oncoproteins and PD-1\/PD-L1 interplay in human cervical cancer: Recent evidence and future directions. Front Oncol. 2020;10:914.","journal-title":"Front Oncol"},{"issue":"12","key":"13299_CR2","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41401-021-00616-5","volume":"42","author":"M Ghanaat","year":"2021","unstructured":"Ghanaat M, Goradel NH, Arashkia A, et al. Virus against virus: Strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer. Acta Pharmacol Sin. 2021;42(12):1981\u201390.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"13299_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/ijgc-2021-002422","volume":"31","author":"M McCormack","year":"2021","unstructured":"McCormack M, Gaffney D, Tan D, et al. The cervical cancer research network (gynecologic cancer intergroup) roadmap to expand research in low- and middle-income countries. Int J Gynecol Cancer. 2021;31(5):775\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"13299_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pop.2018.10.011","volume":"46","author":"SE Stumbar","year":"2019","unstructured":"Stumbar SE, Stevens M, Feld Z. Cervical cancer and its precursors: A preventative approach to screening, diagnosis, and management. Prim Care. 2019;46(1):117\u201334.","journal-title":"Prim Care"},{"issue":"9895","key":"13299_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, et al. Human papillomavirus and cervical cancer. Lancet (London, England). 2013;382(9895):889\u201399.","journal-title":"Lancet (London, England)"},{"issue":"19","key":"13299_CR6","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1111\/febs.14193","volume":"284","author":"J Poirson","year":"2017","unstructured":"Poirson J, Biquand E, Straub ML, et al. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. FEBS J. 2017;284(19):3171\u2013201.","journal-title":"FEBS J"},{"issue":"7","key":"13299_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: Us preventive services task force recommendation statement. JAMA. 2018;320(7):674\u201386.","journal-title":"JAMA"},{"key":"13299_CR8","doi-asserted-by":"crossref","unstructured":"Nkwabong E, Laure Bessi Badjan I, Sando Z. Pap smear accuracy for the diagnosis of cervical precancerous lesions. Trop Doct. 2019;49(1):34-39.","DOI":"10.1177\/0049475518798532"},{"key":"13299_CR9","doi-asserted-by":"crossref","unstructured":"Er G\u00fcneri S, \u015een S. Women's experiences after abnormal pap smear results: a qualitative study. J Psychosom Obstet Gynaecol. 2020;41(1):22-29.","DOI":"10.1080\/0167482X.2019.1657090"},{"issue":"1","key":"13299_CR10","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/s41467-022-30190-1","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Qiu Q, Zhou Q, et al. Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer. Nat Commun. 2022;13(1):2563.","journal-title":"Nat Commun"},{"issue":"3","key":"13299_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/1471-0528.17597","volume":"131","author":"T Hu","year":"2024","unstructured":"Hu T, Li K, He L, et al. Testing for viral DNA integration among HPV-positive women to detect cervical precancer: an observational cohort study. BJOG. 2024;131(3):309\u201318.","journal-title":"BJOG"},{"issue":"3","key":"13299_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/1055-9965.EPI-20-0833","volume":"30","author":"A el Aliani","year":"2021","unstructured":"el Aliani A, El-Abid H, el Mallali Y, et al. Association between gene promoter methylation and cervical cancer development: Global distribution and a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2021;30(3):450\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13299_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fgene.2020.00347","volume":"11","author":"H Zhu","year":"2020","unstructured":"Zhu H, Zhu H, Tian M, et al. DNA methylation and hydroxymethylation in cervical cancer: diagnosis, prognosis and treatment. Front Genet. 2020;11:347.","journal-title":"Front Genet"},{"issue":"10","key":"13299_CR14","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-21-3710","volume":"28","author":"R van den Helder","year":"2022","unstructured":"van den Helder R, Steenbergen RDM, van Splunter AP, et al. HPV and DNA methylation testing in urine for cervical intraepithelial neoplasia and cervical cancer detection. Clin Cancer Res. 2022;28(10):2061\u20138.","journal-title":"Clin Cancer Res"},{"key":"13299_CR15","doi-asserted-by":"crossref","unstructured":"G\u00fczel C, Van Sten-van't Hoff J, De Kok I, et al. Molecular markers for cervical cancer screenin. Expert Rev Proteomics. 2021;18(8):675\u2013691.","DOI":"10.1080\/14789450.2021.1980387"},{"issue":"8","key":"13299_CR16","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41591-024-03014-6","volume":"30","author":"L Schreiberhuber","year":"2024","unstructured":"Schreiberhuber L, Barrett JE, Wang J, et al. Cervical cancer screening using DNA methylation triage in a real-world population. Nat Med. 2024;30(8):2251\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"13299_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41416-023-02277-z","volume":"129","author":"L Verhoef","year":"2023","unstructured":"Verhoef L, Bleeker MCG, Polman N, et al. Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening. Br J Cancer. 2023;129(1):104\u201311.","journal-title":"Br J Cancer"},{"issue":"42","key":"13299_CR18","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.18632\/oncotarget.6250","volume":"6","author":"A Yin","year":"2015","unstructured":"Yin A, Zhang Q, Kong X, et al. Jam3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix. Oncotarget. 2015;6(42):44373\u201387.","journal-title":"Oncotarget"},{"issue":"3","key":"13299_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.506","volume":"7","author":"C Fang","year":"2019","unstructured":"Fang C, Wang SY, Liou YL, et al. The promising role of PAX1 (Aliases: HUP48, OFC2) gene methylation in cancer screening. Mol Genet Genomic Med. 2019;7(3): e506.","journal-title":"Mol Genet Genomic Med"},{"issue":"19","key":"13299_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.21037\/atm.2016.09.30","volume":"4","author":"Y Chen","year":"2016","unstructured":"Chen Y, Cui Z, Xiao Z, et al. PAX1 AND SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians. Ann Transl Med. 2016;4(19):365.","journal-title":"Ann Transl Med"},{"issue":"5","key":"13299_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.canep.2015.07.008","volume":"39","author":"C Nikolaidis","year":"2015","unstructured":"Nikolaidis C, Nena E, Panagopoulou M, et al. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: A meta-analysis. Cancer Epidemiol. 2015;39(5):682\u20136.","journal-title":"Cancer Epidemiol"},{"issue":"13","key":"13299_CR22","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMp1606181","volume":"375","author":"Z Obermeyer","year":"2016","unstructured":"Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med. 2016;375(13):1216\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"13299_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5664\/jcsm.7578","volume":"15","author":"A Ferre","year":"2019","unstructured":"Ferre A, Poca MA, de la Calzada MD, et al. A conditional inference tree model for predicting sleep-related breathing disorders in patients with chiari malformation type 1: Description and external validation. J Clin Sleep Med. 2019;15(1):89\u201399.","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"13299_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol. 2015;123(5):271\u201381.","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"13299_CR25","doi-asserted-by":"publisher","first-page":"15128","DOI":"10.1038\/s41598-021-94635-1","volume":"11","author":"B Gao","year":"2021","unstructured":"Gao B, Liou YL, Yu Y, et al. The characteristics and risk factors of human papillomavirus infection: An outpatient population-based study in Changsha, hunan. Sci Rep. 2021;11(1):15128.","journal-title":"Sci Rep"},{"key":"13299_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/938780","volume":"2012","author":"P Tao","year":"2012","unstructured":"Tao P, Zheng W, Wang Y, et al. Sensitive HPV genotyping based on the flow-through hybridization and gene chip. J Biomed Biotechnol. 2012;2012: 938780.","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"13299_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/AOG.0b013e318254f90c","volume":"120","author":"J Bornstein","year":"2012","unstructured":"Bornstein J, Bentley J, B\u00f6SZE P, et al. 2011 colposcopic terminology of the international federation for cervical pathology and colposcopy. Obstet Gynecol. 2012;120(1):166\u201372.","journal-title":"Obstet Gynecol"},{"key":"13299_CR28","doi-asserted-by":"crossref","unstructured":"H\u00f6hn AK, Brambs CE, Hiller GGR, et al. 2020 WHO classification of female genital tumors. Geburtshilfe Frauenheilkd. 2021;81(10):1145\u20131153.","DOI":"10.1055\/a-1545-4279"},{"issue":"1","key":"13299_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13148-024-01731-w","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Jin X, Kong L, et al. Triage performance of PAX1(m)\/JAM3(m) in opportunistic cervical cancer screening of non-16\/18 human papillomavirus-positive women: a multicenter prospective study in china. Clin Epigenetics. 2024;16(1):108.","journal-title":"Clin Epigenetics"},{"issue":"12","key":"13299_CR30","first-page":"1820","volume":"48","author":"X Li","year":"2023","unstructured":"Li X, He S, Zhao X, et al. High-grade cervical lesions diagnosed by JAM3\/PAX1 methylation in high-risk human papillomavirus-infected patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48(12):1820\u20139.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"39","key":"13299_CR31","doi-asserted-by":"publisher","first-page":"65281","DOI":"10.18632\/oncotarget.18370","volume":"8","author":"PH Su","year":"2017","unstructured":"Su PH, Hsu YW, Huang RL, et al. Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer. Oncotarget. 2017;8(39):65281\u201391.","journal-title":"Oncotarget"},{"issue":"11","key":"13299_CR32","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends in genetics\u202f: TIG. 2021;37(11):1012\u201327.","journal-title":"Trends in genetics : TIG"},{"key":"13299_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.831949","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Tan W, Yang H, et al. Detection of host cell gene\/HPV DNA methylation markers: a promising triage approach for cervical cancer. Front Oncol. 2022;12: 831949.","journal-title":"Front Oncol"},{"key":"13299_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13148-016-0196-3","volume":"8","author":"A Boers","year":"2016","unstructured":"Boers A, Wang R, van Leeuwen RW, et al. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2\/3. Clin Epigenetics. 2016;8:29.","journal-title":"Clin Epigenetics"},{"issue":"6","key":"13299_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/bjc.2014.392","volume":"111","author":"A Boers","year":"2014","unstructured":"Boers A, Bosgraaf RP, van Leeuwen RW, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer. 2014;111(6):1095\u2013101.","journal-title":"Br J Cancer"},{"issue":"5","key":"13299_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/mab.2016.0029","volume":"35","author":"R Feederle","year":"2016","unstructured":"Feederle R, Gerber JK, Middleton A, et al. Generation of PAX1\/PAX1-specific monoclonal antibodies. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2016;35(5):259\u201362.","journal-title":"Monoclonal antibodies in immunodiagnosis and immunotherapy"},{"issue":"10","key":"13299_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ijgc-2019-001144","volume":"30","author":"H Liu","year":"2020","unstructured":"Liu H, Meng X, Wang J. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening. Int J Gynecol Cancer. 2020;30(10):1488\u201392.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"13299_CR38","first-page":"1674","volume":"8","author":"J Xu","year":"2015","unstructured":"Xu J, Xu L, Yang B, et al. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer. Int J Clin Exp Pathol. 2015;8(2):1674\u201381.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"13299_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1186\/s12885-024-12696-7","volume":"24","author":"M Huang","year":"2024","unstructured":"Huang M, Wang T, Li M, et al. Evaluating PAX1 methylation for cervical cancer screening triage in non-16\/18 hrHPV-positive women. BMC Cancer. 2024;24(1):913.","journal-title":"BMC Cancer"},{"key":"13299_CR40","doi-asserted-by":"publisher","first-page":"h2372","DOI":"10.1136\/bmj.h2372","volume":"350","author":"A Goodman","year":"2015","unstructured":"Goodman A. HPV testing as a screen for cervical cancer. BMJ. 2015;350:h2372.","journal-title":"BMJ"},{"issue":"7","key":"13299_CR41","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/cam4.3653","volume":"10","author":"M Wang","year":"2021","unstructured":"Wang M, Hou B, Wang X, et al. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ascus triage. Cancer Med. 2021;10(7):2482\u20138.","journal-title":"Cancer Med"},{"issue":"2","key":"13299_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.31557\/APJCP.2020.21.2.473","volume":"21","author":"S Oranratanaphan","year":"2020","unstructured":"Oranratanaphan S, Kobwitaya K, Termrungruanglert W, et al. Value of CCNA1 promoter methylation in triaging ASC-US cytology. Asian Pacific journal of cancer prevention\u202f: APJCP. 2020;21(2):473\u20137.","journal-title":"Asian Pacific journal of cancer prevention : APJCP"},{"issue":"11","key":"13299_CR43","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","volume":"121","author":"H Kelly","year":"2019","unstructured":"Kelly H, Benavente Y, Pavon MA, et al. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): A systematic review and meta-analysis. Br J Cancer. 2019;121(11):954\u201365.","journal-title":"Br J Cancer"},{"key":"13299_CR44","doi-asserted-by":"crossref","unstructured":"Brancaccio M, Natale F, Falco G, et al. Cell-free DNA methylation: the new frontiers of pancreatic cancer biomarkers' discovery. Genes. 2019:11(1):14.","DOI":"10.3390\/genes11010014"},{"key":"13299_CR45","doi-asserted-by":"crossref","unstructured":"Ciechomska M, Roszkowski L, Maslinski W. DNA methylation as a future therapeutic and diagnostic target in rheumatoid arthritis. Cells. 2019;8(9):953.","DOI":"10.3390\/cells8090953"},{"issue":"1","key":"13299_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3892\/ol.2020.11625","volume":"20","author":"P Yanatatsaneejit","year":"2020","unstructured":"Yanatatsaneejit P, Chalertpet K, Sukbhattee J, et al. Promoter methylation of tumor suppressor genes induced by human papillomavirus in cervical cancer. Oncol Lett. 2020;20(1):955\u201361.","journal-title":"Oncol Lett"},{"key":"13299_CR47","volume":"26","author":"AT Ramirez","year":"2023","unstructured":"Ramirez AT, Valls J, Baena A, et al. Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: An analysis within the ESTAMPA study. Lancet Reg Health Am. 2023;26: 100593.","journal-title":"Lancet Reg Health Am"},{"issue":"5","key":"13299_CR48","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602\u20138.","journal-title":"J Obstet Gynaecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13299-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:07:38Z","timestamp":1734538058000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13299-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13299"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13299-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the Third Xiangya Hospital of Central South University (No. 23137). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1514"}}